WO1990012537A1 - Method of measuring the flow within a blood vessel and device for performing the method - Google Patents

Method of measuring the flow within a blood vessel and device for performing the method Download PDF

Info

Publication number
WO1990012537A1
WO1990012537A1 PCT/SE1990/000244 SE9000244W WO9012537A1 WO 1990012537 A1 WO1990012537 A1 WO 1990012537A1 SE 9000244 W SE9000244 W SE 9000244W WO 9012537 A1 WO9012537 A1 WO 9012537A1
Authority
WO
WIPO (PCT)
Prior art keywords
blood
light
vessel
detected
conductor
Prior art date
Application number
PCT/SE1990/000244
Other languages
English (en)
French (fr)
Inventor
Erik Stenow
Lars Tenerz
Åke ÖBERG
Original Assignee
Radi Medical Systems Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radi Medical Systems Ab filed Critical Radi Medical Systems Ab
Publication of WO1990012537A1 publication Critical patent/WO1990012537A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026Measuring blood flow
    • A61B5/0275Measuring blood flow using tracers, e.g. dye dilution
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/026Measuring blood flow
    • A61B5/0261Measuring blood flow using optical means, e.g. infrared light

Definitions

  • the present invention relates to a method of in situ measuring the flow within a blood vessel, e.g. a coronary heart vessel.
  • a known method for measuring blood flow makes use of an optical method based on Doppler-shift technique.
  • a probe is applied to the skin and lightens a blood vessel. The light is reflected by blood corpuscles and, due to the movement of the blood corpuscles, undergoes a frequency shift, so called Doppler- shift.
  • Doppler-shift On the basis of the extent of the Doppler-shift it is thereafter theoretically possible to calculate the volume flow in the blood vessel illuminated by the probe.
  • a disadvantage of the known technique resides in the fact that the circuits with which the Doppler-shifted signal is detected and filtered are complex and are unable to measure the Doppler-shift with a satisfactory exactitude.
  • Another disadvantage of the Doppler-shift technique resides in the fact that the measuring result is dependent on the position within the cross-section of the blood vessel taken by the sensitive part of the light conductor when introduced into the vessel. It is well known that the speed profile of the flow in a tube is parabolic (when the flow is laminar). In order to be able to determine the flow it is thus necessary to know the position whithin the vessel taken by the optical light conductor, i.e.
  • the light conductor will take a position in which it abuts against the wall of the vessel. It is the purpose of the present invention to achieve a method and an apparatus which eliminate the above-mentioned disadvantages of the known technique and permit measuring in situ of the flow within a blood vessel independently of the position taken by the optical fibre within the blood vessel when inserted therein.
  • the method according to the invention is characterized in that a local disturbance of the optical properties of the blood is provoked at the measuring place, that the disturbance is optically detected by means of an optical conductor intro ⁇ quizged into the vessel, the field of view of this conductor being directed towards the central portion of the vessel, and that the detected optical signal is utilized to produce a measure of the flow.
  • the expression "field of view” refers to the spatial angle of the optical coupling of the light conduc ⁇ tor with the environment. Disturbances may be brought about by causing the light conductor to illuminate the blood with light of a first wave length for producing the natural fluores ⁇ cence of the blood.
  • the disturbance may be brought about by globally adding of a fluorescent substance to the blood to be illuminated from the light conductor with light in order to produce fluorescence, the fluorescent light being measured subsequently.
  • a third alternative is to produce the disturbance of the optical properties of the blood by microbubbles of a gas being introduced locally into the blood at the measuring place and that the bubbles are illuminated with light from the light conductor. The amount of light reflected from the bubbles during their passage past the optical fibre is measured and forms a measure of the volume flow of the blood.
  • a fourth method to produce the disturbance the orientation of the blood corpuscles is locally acted upon in order to produce a local turbulent flow which is illuminated with light from the light conductor.
  • the invention also refers to a device for in situ measuring the flow of blood within a blood vessel.
  • the device according to the invention is characterized in that the end surface of the light conductor is ground in order to cause its field of view to be directed inwardly towards the central portion of the blood vessel and that a light detector is provided in the proximal end of the light conductor to detect a local distur ⁇ saye of the optical properties of the blood, and means for treating the detected light signal for obtaining a measure of the volume flow of the blood.
  • the distal end surface of the light conductor is obliquel ground.
  • Figure 1 schematically shows a device in accordance with the present invention.
  • FIG 2 is a detailed view of the measuring place in Figure 1,
  • Figure 3 is a detailed view of the end portion of a light conductor
  • Figure 4 is a detailed view of an end portion of a modified light conductor
  • Figure 5 shows a conduit into which the light conductor is inserted and through which gas is locally introduced at the measuring position for causing microbubbles to be formed
  • Figure 6 is a side view of a non-pressurized conduit which in accordance with the present invention is used in order to bring about a local disturbance of the orientation of the blood corpuscles
  • Figures 7 and 8 schematically show the orientation of the blood corpuscles prior and after the disturbance of the orientation of the blood corpuscles caused by the conduit according to Figure 6.
  • FIG 1 schematically shows the environment in which the invention is used.
  • a conduit 1 the general construction of which is described in our international patent application PCT/SE87/00347, is introduced via the vena cava into the coronary artery of the heart to the measuring position shown in detail view in Figure 2.
  • the light comes from a light source 2 which, for example, may be an arc lamp or a laser.
  • the light from the light source passes through a filter 3 permitting light of a first wave length to pass.
  • the filtered light is reflected by a semi-transparent mirror 4 and passes through a lens system 5 prior to entering into the proximal end of the conduit.
  • Figure 2 shows how the conduit in a way proposed by the present invention is provided with an opening 6 or a window releasing the light from a light conductor 7 introduced into the conduit against the proximal end surface of which the lens system 5 is focused.
  • the field of view of the light conductor 7 is directed towards the central portion of the vessel as indicated by the broken lines 8 representing the field of view of the light conductor.
  • the coronary vessel has the designation 9.
  • a local distur ⁇ saye of the optical properties of the blood According to the invention four different measures are proposed for bringing about such a disturbance. These methods will be described in detail hereafter.
  • the effect caused by the disturbance on the emitted light with which the blood is illuminated while flowing past the field of view 8 of the light conductor is also detected by the end portion of the light conductor and this light spreads in the light conductor 7 rearwardly against the incoming light and passes through the semi-transparent mirror 4, a second filter 10 to be detected by a photo-multi- plyer 11 in which the light signal is reinforced and converted into an electric signal which thereafter is processed in electrical circuits, not shown, for obtaining a singnal repre ⁇ senting a measure of the volume flow of the blood in the coronary artery of the heart.
  • Figure 3 schematically shows how the end surface of the optical fibre of the light conductor 7 is bevelled in order to direct - based on the total reflection or alternatively by steam-application of a reflective metal layer on the fibre end - the incoming light inward towards the centre of the blood vessel.
  • the light conductor has side-viewing properties.
  • the field of view of the light conductor is indicated by broken lines 8 and the flow direction of the blood is indicated by the continuous arrow whereas the path of the central light ray is designated by the broken arrow.
  • Figure 4 shows another embodiment of the light conductor in which the optical fibre of the light conductor is ground plain so that the field of view of the light conductor extends in the downstream direction. Also here the field of view of the light conductor is defined by broken lines, the path of a central light ray by a broken arrow and the flow direction of the blood by a continuous arrow.
  • the embodiment according to Figure 4 is not side-viewing to the same high degree as the embodiment according to Figure 3 but is satisfactory if the disturbances are produced with the conductor shown in Figures 6 and 7.
  • the local disturbance changing the optical properties of the blood can be of one of the follwing four types:
  • To the optical conductor light is transmitted having a wave length optically exciting the marked blood corpuscles.
  • the filter 3 produces this light frequency. When the light meets a marked blood corpuscle, the blood corpuscle will fluoresce and emit light of a different wave length. This light is reflected in a backward direction towards the end of the optical conduit.
  • the filter 10 transmits this wave length to the photomultiplyer 9.
  • the signal from the photomultiplyer may be used to measure the time during which the marked blood corpuscle remains within the field of view 7 of the light conductor. Knowledge regarding the distance passed by the marked blood corpuscle during the said time permits the speed of the blood corpuscle to be calculated.
  • the distance is defined, for example, by the width of the field of view.
  • the volume flow can be calcu ⁇ lated provided the cross-sectional area of the vessel is known, this area being found, for example, by ultra sound examination or contrast X-ray examination.
  • Other suitable substances are aridine orange, acridine red, XRITC, DTAF, fluorescent benzimidasol derivatives H33258 and H33342.
  • Figure 2 shows how a marked blood corpuscle enters into the field of view of the light conductor and is fluorescing there.
  • the local disturbance in this case is produced by exciting or illuminating the marked blood corpuscles.
  • auto-phosphorescence Another way of bringing about a local disturbance is based on a closely related phenomenon called auto-phosphorescence. All organic substances have a natural fluorescence and a natural phosphorescence if the substance in question is excited by light of suitable wave length. Natural fluorescence is rela ⁇ tively easily discovered at low temperature but is subject in the present case to the disadvantage that the light phenomenon is extremely short (order of magnitude some nano seconds) .
  • the autophosphoroscence is relatively durable, up to some seconds. The autophosphoroscence reduces when the temperature increases. The most normal working temperature for phosphorescence is 77 C K. However, there are some substances performing phosphorescence at room temperature (compare Lloyd J: B.F. 1979). Talanta 26, 180. In this case the autophospho- rescent substance is excited by briefly illuminating the light conductor whith light of a suitable wave length obtained by suitable choice of the filter 3. The fluorescent light is detected in the same way as in the preceding example.
  • the integral of the signal also here will be a measure of the volume passing by and thereby also of the volume flow.
  • a third way of producing a local disturbance of the optical properties of the blood is illustrated in Figure 5 and com ⁇ prises causing a gas introduced into the proximal end of the conductor to be emitted through the fine opening 12 provided in the mantle 13 of the conduit.
  • This causes a zone of micro ⁇ bubbles to be conducted by the blood past the field of view 7 of the light conductor to be gradually absorbed by the blood.
  • the gas may, for example, be air, oxygene or another suitable gas.
  • the light bubbles are illuminated by light from the light source and the bubbles reflect the light back towards the light conductor as if they were bright steel balls (total reflection).
  • the conduit 6 is shown to have a soft, flexible spirally wound point 14 and the light conductor is surrounded by a spiral 15.
  • An arrangement explaining how the gas may be introduced into the conduit is described in our Swedish patent application 8801517-7 and comprises a cylinder sealingly surrounding the mantle of the conduit, the light conductor extending through this cylinder which in one of its end surfaces has a connec ⁇ tion to the conduit 1.
  • a side tube is provided having a Luer-connection to which gas is attached.
  • Bubbles may also be provided in ways different from those shown. For example it is possible to perform local electrolysis of blood upstreams in relation to the measuring position.
  • FIG. 6 A fourth way to bring about a local change of the optical properties of the blood is shown in Figure 6.
  • the outer surface of the conduit 6 is provided with a balloon 16 which via an opening 17 in the mantle of the conduit is connected to a duct 18 which during a short period is pres ⁇ surized by a gas with subsequent discharge of the pressure, causing the balloon 16 to produce a disturbance of the laminar flow of the blood corpuscles.
  • the blood corpuscles are assumed to arrange themself according to the law of least resistance, i.e. laying in the direction of flow. If the laminar flow is disturbed in the way as described the orientation of the blood corpuscles will be changed.
  • Figure 7 shows the orientation of the blood corpuscles prior to the disturbance
  • Figure 8 the orientation of the blood corpuscles after the disturbance.
  • the reflected light is detected and amplified in the photomul ⁇ tiplyer 11.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Cardiology (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
PCT/SE1990/000244 1989-04-14 1990-04-09 Method of measuring the flow within a blood vessel and device for performing the method WO1990012537A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE8901358-5 1989-04-14
SE8901358A SE8901358D0 (sv) 1989-04-14 1989-04-14 Saett att maeta floedet i ett blodkaerl samt anordning haerfoer

Publications (1)

Publication Number Publication Date
WO1990012537A1 true WO1990012537A1 (en) 1990-11-01

Family

ID=20375677

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE1990/000244 WO1990012537A1 (en) 1989-04-14 1990-04-09 Method of measuring the flow within a blood vessel and device for performing the method

Country Status (2)

Country Link
SE (1) SE8901358D0 (sv)
WO (1) WO1990012537A1 (sv)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997012210A1 (en) * 1995-09-29 1997-04-03 Swee Chuan Tjin Fiber optic catheter for accurate flow measurements
US5706808A (en) * 1995-01-31 1998-01-13 Kleinerman; Marcos Y. Fiber optic system for measuring cardiac output
WO1998025513A3 (en) * 1996-12-09 1998-08-27 Swee Chuan Tjin Apparatus for continuous cardiac output monitoring
WO2005009233A1 (en) * 2003-07-25 2005-02-03 Philips Intellectual Property & Standards Gmbh Means for performing measurements in a vessel
CN105658138A (zh) * 2013-06-14 2016-06-08 诺瓦达克技术公司 使用荧光介导的光容积描记术定量组织中的绝对血流量
US10311567B2 (en) 2015-09-23 2019-06-04 Novadaq Technologies ULC Methods and systems for assessing healing of tissue
US10426361B2 (en) 2013-06-14 2019-10-01 Novadaq Technologies ULC Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography
US10646128B2 (en) 2016-02-16 2020-05-12 Novadaq Technologies ULC Facilitating assessment of blood flow and tissue perfusion using fluorescence-mediated photoplethysmography

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3068742A (en) * 1959-06-15 1962-12-18 American Optical Corp Means for performing colorimetry
DE2132864A1 (de) * 1970-09-30 1972-04-06 American Optical Corp Fiberoptisches Katheter
US4341223A (en) * 1981-02-04 1982-07-27 Lutz Lauralee A Fluoresceable composition and method of determining fluid flow
EP0059032A1 (en) * 1981-02-03 1982-09-01 Virgil B. Elings Measurement of dye concentration in the bloodstream
GB2108675A (en) * 1981-10-23 1983-05-18 Draegerwerk Ag Measuring probe
US4487075A (en) * 1983-04-15 1984-12-11 The United States Of America As Represented By The United States Department Of Energy Hydraulic flow visualization method and apparatus
WO1985003855A1 (en) * 1984-03-08 1985-09-12 Optical Technologies, Inc. Fluid flow sensing apparatus for in vivo and industrial applications emloying novel differential optical fiber pressure sensors
US4641658A (en) * 1984-10-01 1987-02-10 American Hospital Supply Corp. Cardiac flow monitor
US4691709A (en) * 1986-07-01 1987-09-08 Cordis Corporation Apparatus for measuring velocity of blood flow in a blood vessel

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3068742A (en) * 1959-06-15 1962-12-18 American Optical Corp Means for performing colorimetry
DE2132864A1 (de) * 1970-09-30 1972-04-06 American Optical Corp Fiberoptisches Katheter
EP0059032A1 (en) * 1981-02-03 1982-09-01 Virgil B. Elings Measurement of dye concentration in the bloodstream
US4341223A (en) * 1981-02-04 1982-07-27 Lutz Lauralee A Fluoresceable composition and method of determining fluid flow
GB2108675A (en) * 1981-10-23 1983-05-18 Draegerwerk Ag Measuring probe
US4487075A (en) * 1983-04-15 1984-12-11 The United States Of America As Represented By The United States Department Of Energy Hydraulic flow visualization method and apparatus
WO1985003855A1 (en) * 1984-03-08 1985-09-12 Optical Technologies, Inc. Fluid flow sensing apparatus for in vivo and industrial applications emloying novel differential optical fiber pressure sensors
US4641658A (en) * 1984-10-01 1987-02-10 American Hospital Supply Corp. Cardiac flow monitor
US4691709A (en) * 1986-07-01 1987-09-08 Cordis Corporation Apparatus for measuring velocity of blood flow in a blood vessel

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PATENT ABSTRACTS OF JAPAN, Vol. 8, No. 137, P282; & JP,A,5 938 615 (02-03-94) SUMITOMO DENKI KOGYO K.K. *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5706808A (en) * 1995-01-31 1998-01-13 Kleinerman; Marcos Y. Fiber optic system for measuring cardiac output
WO1997012210A1 (en) * 1995-09-29 1997-04-03 Swee Chuan Tjin Fiber optic catheter for accurate flow measurements
WO1998025513A3 (en) * 1996-12-09 1998-08-27 Swee Chuan Tjin Apparatus for continuous cardiac output monitoring
US6325762B1 (en) 1996-12-09 2001-12-04 Swee Chuan Tjin Method and apparatus for continuous cardiac output monitoring
WO2005009233A1 (en) * 2003-07-25 2005-02-03 Philips Intellectual Property & Standards Gmbh Means for performing measurements in a vessel
EP3007618A4 (en) * 2013-06-14 2017-05-31 Novadaq Technologies Inc. Quantification of absolute blood flow in tissue using fluorescence mediated photoplethysmography
CN105658138A (zh) * 2013-06-14 2016-06-08 诺瓦达克技术公司 使用荧光介导的光容积描记术定量组织中的绝对血流量
US10285603B2 (en) 2013-06-14 2019-05-14 Novadaq Technologies ULC Quantification of absolute blood flow in tissue using fluorescence mediated photoplethysmography
US10426361B2 (en) 2013-06-14 2019-10-01 Novadaq Technologies ULC Quantification of absolute blood flow in tissue using fluorescence-mediated photoplethysmography
US11696695B2 (en) 2013-06-14 2023-07-11 Stryker European Operations Limited Quantification of absolute blood flow in tissue using fluorescence mediated photoplethysmography
US10311567B2 (en) 2015-09-23 2019-06-04 Novadaq Technologies ULC Methods and systems for assessing healing of tissue
US10636144B2 (en) 2015-09-23 2020-04-28 Novadaq Technologies ULC Methods and systems for assessing healing of tissue
US10646128B2 (en) 2016-02-16 2020-05-12 Novadaq Technologies ULC Facilitating assessment of blood flow and tissue perfusion using fluorescence-mediated photoplethysmography
US11701016B2 (en) 2016-02-16 2023-07-18 Stryker European Operations Limited Facilitating assessment of blood flow and tissue perfusion using fluorescence-mediated photoplethysmography

Also Published As

Publication number Publication date
SE8901358D0 (sv) 1989-04-14

Similar Documents

Publication Publication Date Title
US20040019280A1 (en) Infrared assisted monitoring of a catheter
Ranke et al. Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction
US6615062B2 (en) Referencing optical catheters
EP0359433B1 (en) Physiological probe
Cothren et al. Gastrointestinal tissue diagnosis by laser-induced fluorescence spectroscopy at endoscopy
US5817009A (en) Arrangement for noninvasive determination of the oxygen saturation in human blood vessels or organs
JP6335909B2 (ja) ハイブリッドカテーテルシステム
US6949072B2 (en) Devices for vulnerable plaque detection
Jain et al. Influence of various instrument settings on the flow information derived from the power mode
US6205352B1 (en) Sentinel node identification using non-isotope means
WO1999030608A1 (en) Apparatus and method for determining tissue characteristics
JP2006317319A (ja) 血管診断用分光プローブ
JPH05228154A (ja) 対象物の検査のための組織光学的測定装置
CN105916457A (zh) 用于形成血管通路的装置和方法
WO2003030726A1 (fr) Procede de detection automatique, et de traitement ou d'echantillonnage de partie d'objet, du type partie d'objet affectee, et appareil correspondant
WO1995026673A3 (en) Apparatus and method for imaging diseased tissue using integrated autofluorescence
JP2007313169A (ja) 病変抽出装置および病変抽出方法
JPH06504686A (ja) 超音波画像システム及び同用音波部材
US5690115A (en) Detecting vascular stenosis in chronic hemodialysis patients
WO1990012537A1 (en) Method of measuring the flow within a blood vessel and device for performing the method
US20100020163A1 (en) Fluorescence endoscope
CN109497964A (zh) 一种基于激光光声光谱的人体血管检测系统
WO2000055579A3 (en) A system and method for detection and characterization of stenosis, blood vessels flow and vessel walls properties using vessel geometrical measurements
DE102006050886B4 (de) Medizinisches Instrument und Einrichtung zur Erzeugung von Gewebeschnittbildern
Solen et al. Light-scattering instrument to detect thromboemboli in blood

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LU NL SE